258 related articles for article (PubMed ID: 18851906)
21. Attitudes Toward Medications and the Relationship to Outcomes in Patients with Schizophrenia.
Campbell AH; Scalo JF; Crismon ML; Barner JC; Argo TR; Lawson KA; Miller A
Clin Schizophr Relat Psychoses; 2018; 12(1):12-22. PubMed ID: 26218237
[TBL] [Abstract][Full Text] [Related]
22. Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset.
Fond G; Boyer L; Boucekine M; Aden LA; Schürhoff F; Tessier A; Andrianarisoa M; Berna F; Brunel L; Capdevielle D; Chereau I; Mallet J; Denizot H; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Rey R; Richieri R; Passerieux C; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Misdrahi D;
Schizophr Res; 2017 Apr; 182():84-89. PubMed ID: 27789187
[TBL] [Abstract][Full Text] [Related]
23. Measuring adherence to medication in schizophrenia: the relationship between attitudes toward drug therapy and plasma levels of new-generation antipsychotics.
Yalcin-Siedentopf N; Wartelsteiner F; Kaufmann A; Biedermann F; Edlinger M; Kemmler G; Rettenbacher MA; Widschwendter CG; Zernig G; Fleischhacker WW; Hofer A
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522423
[TBL] [Abstract][Full Text] [Related]
24. Effect of subjective reasoning and neurocognition on medication adherence for persons with schizophrenia.
Maeda K; Kasai K; Watanabe A; Henomatsu K; Rogers MA; Kato N
Psychiatr Serv; 2006 Aug; 57(8):1203-5. PubMed ID: 16870974
[TBL] [Abstract][Full Text] [Related]
25. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
[TBL] [Abstract][Full Text] [Related]
26. Reliability and validity of the Medication Adherence Rating Scale in a cohort of patients with schizophrenia from Nigeria.
Owie GO; Olotu SO; James BO
Trends Psychiatry Psychother; 2018; 40(2):85-92. PubMed ID: 29768528
[TBL] [Abstract][Full Text] [Related]
27. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia.
Dibonaventura M; Gabriel S; Dupclay L; Gupta S; Kim E
BMC Psychiatry; 2012 Mar; 12():20. PubMed ID: 22433036
[TBL] [Abstract][Full Text] [Related]
28. Community integration and associated factors among older adults with schizophrenia.
Abdallah C; Cohen CI; Sanchez-Almira M; Reyes P; Ramirez P
Psychiatr Serv; 2009 Dec; 60(12):1642-8. PubMed ID: 19952155
[TBL] [Abstract][Full Text] [Related]
29. Depression in older adults with schizophrenia spectrum disorders: prevalence and associated factors.
Diwan S; Cohen CI; Bankole AO; Vahia I; Kehn M; Ramirez PM
Am J Geriatr Psychiatry; 2007 Dec; 15(12):991-8. PubMed ID: 18056817
[TBL] [Abstract][Full Text] [Related]
30. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
Misdrahi D; Verdoux H; Lançon C; Bayle F
Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
[TBL] [Abstract][Full Text] [Related]
31. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
32. Descriptions and Correlates of Medication Adherence, Attitudes, and Self-Efficacy in Outpatients With Schizophrenia Spectrum Disorders (SSDs).
Beebe LH; Smith K; Phillips C
Arch Psychiatr Nurs; 2016 Jun; 30(3):400-5. PubMed ID: 27256948
[TBL] [Abstract][Full Text] [Related]
33. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
35. Novelty seeking and medication adherence in patients with schizophrenia.
Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
[TBL] [Abstract][Full Text] [Related]
36. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
37. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
Wong MM; Chen EY; Lui SS; Tso S
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
[TBL] [Abstract][Full Text] [Related]
38. The impact of self-stigmatization on medication attitude in schizophrenia patients.
Feldhaus T; Falke S; von Gruchalla L; Maisch B; Uhlmann C; Bock E; Lencer R
Psychiatry Res; 2018 Mar; 261():391-399. PubMed ID: 29353769
[TBL] [Abstract][Full Text] [Related]
39. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
40. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia.
Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
Curr Clin Pharmacol; 2012 Feb; 7(1):49-55. PubMed ID: 22299769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
